Mediphage Bioceuticals, founded in 2016, is a spin-off from the University of Waterloo. Mediphage is a gene delivery company located at JLabs in Toronto, Canada. Our proprietary core technology, ministring DNA (msDNA), is novel non-viral gene delivery vector that is designed to overcome critical challenges facing viral gene therapies and leverage advancements of non-viral gene delivery.
Leveraging on versatility of msDNA gene delivery vector, we are developing innovative solutions to the challenges faced with genetic and infectious diseases that have limited, or no treatment options available at present.